Liberty Mutual Group Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27,457	Closed	-$1.48M	–	981
2017 Q4	$1.48M	Sell	27,457 -834	-3%	-$45.6K	0.04%	265
2017 Q3	$1.61M	Sell	28,291 -14,517	-34%	-$850K	0.09%	237
2017 Q2	$2.58M	Sell	42,808 -6,338	-13%	-$361K	0.1%	208
2017 Q1	$2.68M	Buy	+49,146	New	+$2.42M	0.1%	222

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Liberty Mutual Group Asset Management's BIVV Position: Q1 2018 in Review

Liberty Mutual Group Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 27,457 shares — an estimated $1.48M sold.

Liberty Mutual Group Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.68M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Liberty Mutual Group Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Liberty Mutual Group Asset Management sold 27,457 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.48M.
Liberty Mutual Group Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Liberty Mutual Group Asset Management's Bioverativ Inc. Common Stock position peaked at $2.68M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q1 2018, filed 9 May 2018.